Literature DB >> 16680784

How to control NO production in cells: N(omega),N(omega)-dimethyl-L-arginine dimethylaminohydrolase as a novel drug target.

Markus Knipp1.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16680784     DOI: 10.1002/cbic.200500527

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


× No keyword cloud information.
  6 in total

1.  Determination of dimethylarginine dimethylaminohydrolase activity in the kidney.

Authors:  Y-L Tain; C Baylis
Journal:  Kidney Int       Date:  2007-07-25       Impact factor: 10.612

2.  Promiscuous partitioning of a covalent intermediate common in the pentein superfamily.

Authors:  Thomas W Linsky; Arthur F Monzingo; Everett M Stone; Jon D Robertus; Walter Fast
Journal:  Chem Biol       Date:  2008-05

Review 3.  Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables.

Authors:  Christopher S Wilcox
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

4.  Developing an irreversible inhibitor of human DDAH-1, an enzyme upregulated in melanoma.

Authors:  Yun Wang; Shougang Hu; Abdul M Gabisi; Joyce A V Er; Arthur Pope; Gayle Burstein; Christopher L Schardon; Arturo J Cardounel; Suhendan Ekmekcioglu; Walter Fast
Journal:  ChemMedChem       Date:  2014-02-26       Impact factor: 3.466

5.  Discovery of structurally-diverse inhibitor scaffolds by high-throughput screening of a fragment library with dimethylarginine dimethylaminohydrolase.

Authors:  Thomas W Linsky; Walter Fast
Journal:  Bioorg Med Chem       Date:  2012-08-03       Impact factor: 3.641

6.  Specific reactions of S-nitrosothiols with cysteine hydrolases: A comparative study between dimethylargininase-1 and CTP synthetase.

Authors:  Oliver Braun; Markus Knipp; Serge Chesnov; Milan Vasák
Journal:  Protein Sci       Date:  2007-06-28       Impact factor: 6.725

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.